• Users Online: 334
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

 Table of Contents  
CASE REPORT
Year : 2014  |  Volume : 34  |  Issue : 4  |  Page : 183-185

Acute painful ophthalmoplegia in a patient with hepatocellular carcinoma


1 Department of Diving Medicine, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung; Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China
2 Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China

Date of Submission25-Sep-2013
Date of Decision28-Oct-2013
Date of Acceptance19-Dec-2013
Date of Web Publication26-Aug-2014

Correspondence Address:
Dr. Yueh-Feng Sung
Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Cheng-Gong Road, Taipei 114, Taiwan
Republic of China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1011-4564.139195

Rights and Permissions
  Abstract 

We herein describe a 48-year-old man who developed acute painful ophthalmoplegia of the right eye for 5 days. Magnetic resonance imaging of the brain with contrast detected a contrast-enhancing lesion in the right cavernous sinus (CS) and petrous apex. Tolosa-Hunt syndrome was suspected initially, but later he was diagnosed as CS metastasis from hepatocellular carcinoma (HCC). To the best of our knowledge, only nine similar cases have been reported in the literature. We would like to remind clinicians to consider the possibility of CS metastasis in patients with primary HCC, who present with acute painful ophthalmoplegia.

Keywords: Cavernous sinus, hepatocellular carcinoma, ophthalmoplegia, Tolosa-Hunt syndrome


How to cite this article:
Tseng WS, Sung YF. Acute painful ophthalmoplegia in a patient with hepatocellular carcinoma. J Med Sci 2014;34:183-5

How to cite this URL:
Tseng WS, Sung YF. Acute painful ophthalmoplegia in a patient with hepatocellular carcinoma. J Med Sci [serial online] 2014 [cited 2019 Oct 22];34:183-5. Available from: http://www.jmedscindmc.com/text.asp?2014/34/4/183/139195


  Introduction Top


Painful ophthalmoplegia is an uncommon, but important clinical problem to physicians. Clinical approach to patients with painful ophthalmoplegia requires extensive differential diagnoses, including vascular, neoplastic, infectious, and inflammatory lesions. [1] Early diagnosis is essential, and treatment depends on the underlying etiology. In this case report, we describe a patient who developed acute painful ophthalmoplegia of the right eye due to the cavernous sinus (CS) metastasis from hepatocellular carcinoma (HCC).


  Case Report Top


A 48-year-old Taiwanese man with hepatitis B virus (HBV)-related HCC presented to the Emergency Department with a 5-day history of gradual onset of severe boring pain at the medial side of right orbital area and double vision. He denied having head trauma, neck pain, fever, weakness of limbs, or unsteady gait. His past medical history included a right lobectomy of the liver for HCC and transarterial chemoembolization for postoperatively recurrence 10 and 2 years prior to admission, respectively. Sorafenib was prescribed at a starting dose of 200 mg bid because recurrence of HCC with portal vein thrombosis (cT3bN0M0, stage IIIB) was found again 2 months prior to admission.

His initial vital signs were normal. No conjunctival injection, chemosis, proptosis, facial cellulitis, dental abscess, or neck masses were shown. His pupils were 2.5 mm in size and reactive to light. Visual acuity and fundoscopic examinations were normal in both eyes. Cranial nerve examination revealed a decreased ability to abduct the right eye consistent with abducens nerve palsy. The rest of his cranial nerves and neurological examination was unremarkable. His blood tests revealed increased liver function enzymes (glutamate oxaloacetate transaminase 142 U/L, glutamic pyruvic transaminase 89 U/L, and normal range <41 U/L) and inflammatory markers with a C-reactive protein of 2.5 mg/dL (normal range 0-0.5 mg/dL). His alpha-fetoprotein was >500 ng/ml (normal range 0-20 ng/ml). Infection surveys revealed no obvious infection sources. Chest X-ray showed diffuse and numerous soft-tissue nodules in both lungs, suggesting pulmonary metastases. A computed tomography (CT) of the brain without contrast showed no apparent abnormalities. Magnetic resonance imaging (MRI) of the brain with contrast detected a contrast-enhancing lesion in the right CS and petrous apex [Figure 1]. MR angiography showed no remarkable findings.
Figure 1: Right cavernous sinus (CS) metastasis from hepatocellular carcinoma. Contrast-enhanced axial (a) and coronal (b) T1-weighted magnetic resonance images showing a lesion involving the right CS (white arrow)

Click here to view


After hospitalization, corticosteroid was administered on suspicion of Tolosa-Hunt syndrome (THS). However, there was no improvement of his painful ophthalmoplegia after 72 h of corticosteroid therapy. The patient's orbital pain got progressively worse, and 10 days after admission, he developed right total ophthalmoplegia and ptosis. The diagnosis of HCC with distant metastasis to the CS was made. We recommended the patient receive tissue biopsy to confirm the diagnosis, but he refused. Severe pain in his right eye could only be partially relieved by high dose of narcotic analgesics. He declined palliative radiotherapy treatment and received hospice care. The patient eventually succumbed to death one and a half months later.


  Discussion Top


Liver cancer is one of the most common causes of malignancies related deaths worldwide, especially in East and South-East Asia. [2] Among primary liver cancers, HCC represents the major histological subtype, accounting for 70-85% of the total liver cancer worldwide. [2] Extrahepatic metastases are seen in 37% of patients with HCC. [3] Lungs, abdominal lymph nodes, bone marrow, and adrenal glands are commonly metastatic sites of HCC. [3],[4],[5] Brain metastasis from HCC is rare, with a reported frequency ranging from 0.2% to 2.2%. [4],[5]

According to the statistics, breast, lung, and prostate cancers are the most common primary sites with distant metastasis to the CS other than the head and neck cancers. [6] To date, only nine cases of CS metastasis from HCC were reported in the literature [Table 1]. [7],[8],[9],[10],[11],[12],[13] The age of these patients ranged from 40 to 80 years, and 78% of them were male. The majority of them were the carriers of HBV or hepatitis C virus. Most of them died within a short interval ranging from 1 to 12 months after the onset of neurological symptoms, even after surgery or radiotherapy. The management of CS metastasis is palliative. [14] In general, radiotherapy is considered the standard treatment and often results in improvement of symptoms and alleviation of pain. [15] In some patients, early radiosurgery may be associated with improvement of cranial nerve dysfunction. [15],[16] However, the prognosis of HCC with CS metastasis is very poor, and the median survival time is reported to be between 4 and 13 months from the onset of symptoms. [14],[16]
Table 1: Summary of case reports on cavernous sinus metastasis from hepatocellular carcinoma

Click here to view


Tolosa-Hunt syndrome is characterized by painful ophthalmoplegia and is caused by an idiopathic granulomatous inflammation of the CS. Corticosteroid is considered to have diagnostic as well as therapeutic utility. CT scans have been found to be normal in the majority of patients with THS. A contrast-enhanced MRI can play an important role for distinguishing THS from other THS-like entities. [17] MRI of THS shows an enlargement of the CS with isointense to the brain tissue on T1- and T2-weighted images and marked contrast medium enhancement, which is consistent with the MR findings in our patient. Based on the clinical data, our patient was initially diagnosed as THS. However, poor response to steroid therapy prompted us to consider other etiologies. Although the biopsy confirmation was not done in our patient, the progressive neurological deterioration and the evidence of lung metastases were in favor of the diagnosis of HCC with distant metastases to CS.


  Conclusion Top


Painful ophthalmoplegia involves various pathological etiologies of CS in a wide spectrum, from inflammation to malignancies. THS should not be considered as the initial diagnosis for a patient who has had a primary malignancy until metastasis has been excluded by appropriate investigation. In addition, if high-dose steroid therapy fails, and neurological findings and pain are progressive, further studies are necessary to exclude other underlying disorders. A high index of suspicion is needed to survey for CS metastasis from HCC when patients with an HCC history present with painful ophthalmoplegia.


  Disclosure Top


All authors declare no competing financial interests.

 
  References Top

1.La Mantia L, Erbetta A, Bussone G. Painful ophthalmoplegia: An unresolved clinical problem. Neurol Sci 2005;26 Suppl 2:s79-82.  Back to cited text no. 1
    
2.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.  Back to cited text no. 2
    
3.Katyal S, Oliver JH 3 rd , Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703.  Back to cited text no. 3
    
4.Jiang XB, Ke C, Zhang GH, Zhang XH, Sai K, Chen ZP, et al. Brain metastases from hepatocellular carcinoma: Clinical features and prognostic factors. BMC Cancer 2012;12:49.  Back to cited text no. 4
    
5.Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, et al. Brain metastases from hepatocellular carcinoma: Prognostic factors and outcome: Brain metastasis from HCC. J Neurooncol 2009;91:307-13.  Back to cited text no. 5
    
6.Ahn Y, Yang JH, Kim HJ, Jang SE, Jang YJ, Kim HR, et al. Cavernous sinus metastasis of non-small cell lung cancer. Tuberc Respir Dis 2010;69:381-4.  Back to cited text no. 6
    
7.Morita A, Meyer FB, Laws ER Jr. Symptomatic pituitary metastases. J Neurosurg 1998;89:69-73.  Back to cited text no. 7
    
8.Aung TH, Po YC, Wong WK. Hepatocellular carcinoma with metastasis to the skull base, pituitary gland, sphenoid sinus, and cavernous sinus. Hong Kong Med J 2002;8:48-51.  Back to cited text no. 8
    
9.Kato H, Kanematsu M, Goshima S, Kondo H, Nishibori H, Tsuge Y, et al. Skull base metastasis from hepatocellular carcinoma revealed by cranial nerve palsy: Reports of two cases. Eur J Radiol Extra 2005;54:1-4.  Back to cited text no. 9
    
10.Kim SR, Kanda F, Kobessho H, Sugimoto K, Matsuoka T, Kudo M, et al. Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves. World J Gastroenterol 2006;12:6727-9.  Back to cited text no. 10
    
11.Chen SF, Tsai NW, Lui CC, Lu CH, Huang CR, Chuang YC, et al. Hepatocellular carcinoma presenting as nervous system involvement. Eur J Neurol 2007;14:408-12.  Back to cited text no. 11
    
12.Kim SJ, Kim HJ, Lee HW, Choi CH, Kim JU, Do JH, et al. Hepatocellular carcinoma with metastasis to the cavernous sinus of skull base causing ptosis. Korean J Gastroenterol 2008;52:389-93.  Back to cited text no. 12
    
13.Faraji-Rad M, Faraji-Rad E, Mashadinezhad H, Omidi A, Rahrooh M. Single cavernous sinus metastasis as the first manifestation of hepatocellular carcinoma - A rare case report and review of literature. Neurosurg Q 2010;20:203-7.  Back to cited text no. 13
    
14.Spell DW, Gervais DS Jr, Ellis JK, Vial RH. Cavernous sinus syndrome due to metastatic renal cell carcinoma. South Med J 1998;91:576-9.  Back to cited text no. 14
    
15.Laigle-Donadey F, Taillibert S, Martin-Duverneuil N, Hildebrand J, Delattre JY. Skull-base metastases. J Neurooncol 2005;75:63-9.  Back to cited text no. 15
    
16.Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD. The role of palliative radiosurgery when cancer invades the cavernous sinus. Int J Radiat Oncol Biol Phys 2009;73:709-15.  Back to cited text no. 16
    
17.Cakirer S. MRI findings in the patients with the presumptive clinical diagnosis of Tolosa-Hunt syndrome. Eur Radiol 2003;13:17-28.  Back to cited text no. 17
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Case Report
Discussion
Conclusion
Disclosure
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed1774    
    Printed48    
    Emailed0    
    PDF Downloaded103    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]